MedTrace Logo

Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981

NCT06954766 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-04-13

No results posted yet for this study

Summary

The purpose of this study is to prove that the temporary symptom improvement effect on knee osteoarthritis using CKD-981

Conditions

Interventions

DEVICE

CKD-981(1)

20 minutes per day, 5 days a week for 6 weeks.

DEVICE

CKD-981(2)

20 minutes per day, 5 days a week for 6 weeks.

DEVICE

Sham device

20 minutes per day, 5 days a week for 6 weeks.

DRUG

Reference Drug

QD for 6 weeks

DRUG

Placebo Drug

QD for 6 weeks

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-28
Primary Completion
2025-10-28
Completion
2025-10-28

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06954766 on ClinicalTrials.gov